PON1 and COVID-19: Such profound modifications of HDL proteome are also associated with the loss of the antioxidative enzyme PON1, which ultimately leads to HDL dysfunction, as seen in cardiometabolic [21] and malignant diseases [22] but also in COVID-19 [23].